Introduction. When a patient has no suitable vessels for use as grafts in bypass or reconstruction procedures, two of the options available are the use of a cryopreserved vessel or an expanded polytetrafluoroethylene (ePTFE) prosthesis. This study was designed to compare the long-term behaviour of these vascular substitutes. Material and methods. We established three study groups by grafting the following vessel substitutes to the iliac artery in Spraque-Dawley rats: arterial autografts (GI, n ¼ 12), cryopreserved syngenic arterial grafts (cryoisografts) (GII, n ¼ 12), and ePTFE micrografts (GIII, n ¼ 12). The animals were sacrificed 180 days after surgery, at which time the graft specimens were morphologically evaluated by light and electron microscopy, immunolabelling (ED1/a-actin) and morphometric analysis of the neointima. Results. At the time of sacrifice, graft patency was 100% for the autografts and cryoisografts, while 10% of the ePTFE micrografts showed fully-occlusive thrombosis. Intimal hyperplasia was observed in grafts in GI and GII; the neointima being thinner in the cryoisografts (54.36^2.26 mm) than the autografts (161.30^3.91 mm). The endothelium formed over the prosthetic micrografts was unstable, with areas of subendothelial thickening (9.37^3.18 mm). Cell loss and medial layer degeneration were observed in both GI and GII specimens, while the GIII grafts were colonised by cells on their luminal surface.
Introduction
In arterial reconstruction procedures, the use of prosthetic material is an option available to the surgeon when the patient has no suitable vessel. Expanded polytetrafluoroethylene (ePTFE) is one of the most frequently used prostheses in human clinical practice. This biomaterial has several advantages over other prosthetic materials, including high electronegativity and a hydrophobic surface that reduces platelet adhesion. This material also boasts a good blood/biomaterial interface and shows excellent biotolerance on the part of the recipient. 1 The incidence of vascular prosthesis failure is high in a setting of vessels with a small internal diameter. 2, 3 This is mainly attributable to intimal hyperplasia and thrombosis. Prosthetic material is also susceptible to infection, a devastating complication that often requires its withdrawal and replacement.
Another option that has recently generated much interest is the use of cryopreserved vessels from human vessel banks. Over the last few years, these vessels are being increasingly employed in vascular reconstruction procedures, given the developments made in minimising tissue damage induced by low temperatures. Further advances in the cryopreservation/thawing process 4, 5 including the introduction of cryoprotectants have led to their current use in clinical practice. 6 -9 Several authors 10 -12 presently use cryopreserved vessels for the in situ treatment of infections provoked by prosthetic materials.
Despite these advances, there is scarce data on the long-term behaviour of arterial substitutes, bearing in mind the changes occurring in the repair process itself. Our experience based on the repair process in autograft models is that in the long-term, 13, 14 the medial layer becomes acellular. The final situation, therefore, resembles that related to the use of a synthetic ePTFE prosthesis whereby the role played by the graft is to support the vessel wall and act as an inert conducting tube. The aim of the present study was, therefore, to compare the long-term behaviour of cryopreserved arterial grafts with that shown by ePTFE vascular microprostheses when implanted in the experimental animal.
Materials and Methods

Experimental animals
The experimental animal used was the female Sprague -Dawley rat weighing 250 -300 g. All procedures were carried out according to European Union guidelines on the Care and Use of Laboratory Animals (EEC 28871-22A9). Anaesthesia was induced by intraperitoneal ketamine chlorohydrate (0.25 ml/100 g body weight) and diazepam (0.004 ml/100 g body weight). The surgical approach was a midline xypho-pubic laparotomy. The common iliac artery was dissected along its entire course and, with the help of a Gilbert double vascular clamp, a segment 5 mm in length was resected from its middle portion. The length of vessel removed was then replaced with cryopreserved arterial segments of similar length harvested from syngenic rats or with prosthetic ePTFE conduits (W. L. Gore, Flagstaff, AZ, USA) of 1 mm internal diameter and porosity 30 mm. The control group was formed by autografts performed in the experimental animals using the same surgical technique. In this control group, a segment of similar length (5 mm) was resected from the middle portion of the iliac artery and immediately reimplanted in the same position by two end-to-end anastomoses. A ZEISS 650 microscope was used for the microsurgery technique used by our team in previous studies. 13, 14 In all the surgical procedures, blood flow was restored by securing the grafts by two end-to-end anastomoses comprised of loose ethilon 10/0 monofilament (Ethilon, Ethicon w ) stitches. Graft patency was visually confirmed following anastomosis. Though the surgical technique was non-sterile, the grafts were sterilised in ethylene oxide prior to implant. Neither local nor general anticoagulation was used.
Cryopreserving and thawing the arterial grafts
Iliac arteries harvested from donor animals were washed in minimum essential medium (MEM) to remove all traces of blood and placed in cryotubes containing the same medium supplemented with 20% foetal bovine serum (FBS) and 10% dimethylsulphoxide (DMSO). To reduce its toxicity, the DMSO was added in 4 £ 5 min steps in which its concentration was increased to 10%. The vessels were subjected to automated, controlled freezing in a biological freezer (CM25 P.115, Carburos Metálicos S.A., Spain) at a mean temperature reduction rate of 1 8C/min to 2 120 8C.
The frozen arterial segments were stored in liquid nitrogen vapour at 2 145 8C for 30 days. After this storage period, the specimens were transferred from the liquid nitrogen tank to the freezing chamber where they were thawed according to a slow, automated thawing programme established in our laboratory 5,15 at a warming rate of 1 8C/min to room temperature. Once thawed, the cryoprotectant was removed gradually in tapered dilutions and the cryografts implanted in syngenic recipients to avoid rejection.
Experimental design
The animals were grouped according to the type of graft implanted as:
GI ðn ¼ 12Þ: fresh arterial autografts GII ðn ¼ 12Þ: cryopreserved arterial isografts GIII ðn ¼ 12Þ: ePTFE micrografts.
The animals were sacrificed at 180 days postsurgery. Just before sacrifice, they were reoperated on to perfuse the vascular tree (at a pressure of 100 mmHg via a catheter placed in the left ventricle), first with Ringer's lactate, to wash out all the blood, and then with the appropriate solution for the subsequent analysis. All the explanted grafts were tested for infection at the time of extraction.
Morphological evaluation
Grafts for light microscopy examination were perfused with 10% formaldehyde and embedded in paraffin to obtain sections 5 mm-thick. Once deparaffinated and hydrated, the specimens were stained with haematoxylin-eosin, orcein and Masson's trichrome stains.
For ultrastructural analysis, the solution used for graft perfusion was a 2:1 mixture of glutaraldehyde (3%) -paraformaldehyde (2%) in Millonig buffer (pH 7.3), to avoid tissue retraction and achieve good fixing. After the perfusion process, the grafted segment was removed along with a small band of recipient artery at each end of the graft. Small graft fragments were then fixed for 1 h in 3% glutaraldehyde, stored in Millonig buffer (pH 7.3) and postfixed in 2% osmium tetroxide. Once dehydrated in a graded series of acetone, the specimens were embedded in Araldite to obtain thin cuts. These sections were counterstained with lead citrate and examined using a Zeiss 109 transmission electron microscope.
For scanning electron microscopy (SEM), the graft specimens were opened longitudinally and immersed in 3% glutaraldehyde. Next, they were transferred to Millonig buffer (pH 7.3) for 1 h and dehydrated in a graded acetone series reaching critical point in a Polaron E 3000 instrument with CO 2 . Once metallised with palladium-gold, the specimens were examined using a Zeiss 950 DSM scanning electron microscope.
Immunohistochemical analysis
Antibodies specific for rat monocytes/macrophages (MCA 341, Serotec) and smooth muscle cells (a-actin, Sigma) were used in the alkaline phosphatase-labelled avidin -biotin procedure. The chromogenic substrate contained alpha-naphtol and fast-red. Nuclei were counterstained with Carazzi haematoxylin.
Morphometry and cell quantification
Morphometric measurements were made using a Microm computerised image analyser (Microm) on 10 transverse tissue sections per specimen examined under the 40 £ lens of the light microscope. Each section was divided into 4 sectors and an optical field was randomly selected from each sector for ED1positive cell counts and to measure the thickness of the neointima.
The thickness of the neointima was determined in sections of the grafts stained with orcein, haematoxylin-eosin or Masson's trichrome stains, as the distance from the endothelial layer to the internal elastic lamina, which forms the border with the medial layer. 
Statistical analysis
Statistical analysis was performed using non-parametric statistics. The thickness of the neointima and the proportion of ED1-positive cells were compared among the study groups by the Mann -Whitney U-test. The level of significance was set at p , 0:05:
Results
At the time of extraction, all the autografts (GI) and cryoisografts (GII) were patent, though one of the GII grafts was partially thrombosed. In contrast, 10% of the ePTFE prostheses (GIII) showed fully occlusive thrombosis at the time of sacrifice. None of the 36 explanted grafts showed signs of infection.
Morphological analysis
In the autografts, the neointima was fairly thick ( Fig. 1(a) ) and extended across both the grafted segment and adjacent areas of the recipient artery. This new arterial tunica was formed by a monolayer of endothelial cells ( Fig. 1(b) ) and several strata of proliferative smooth muscle cells lining the luminal surface ( Fig. 1(c) ). Around these layers and infilling intercellular spaces, small amounts of extracellular matrix with disperse elastin deposits were identified. The myointima extended across the clamped section of the artery, completely covering the suture stitches. The thickness of this neolayer was greater than that of the native muscle layer. The latter had changed its morphology to become an acellular layer containing elastic laminae, which take up the appearance of piles of coins embedded in an extracellular matrix made up of debris ( Fig. 1(a) ).
The arterial cryoisografts were covered by a concentric neointima several cell layers thick ( Fig. 2(a) ). The luminal surface of the grafted segment was formed by a continuous, uniform endothelium ( Fig. 2(b) ). These intimal cells showed the typical elongated morphology (Fig. 2(c) ). The medial layer of the graft was degenerated with complete cell loss ( Fig. 2(c) ). Its general appearance was one of a thinned, acellular layer that was almost exclusively made up of elastic laminae, some of which were fragmented. The different elastic laminae were organised as tight bundles of fibres that ran parallel and concentric to the vessel lumen. Between laminae it was barely possible to discern thin bands of interstitial matrix separating them, in which only filamentous elements and amorphous material could be seen.
After 6 months of implant, the inside of the ePTFE microprostheses had become colonised with cells ( Fig. 3(a) ) and, in zones close to the sites of anastomoses, small neoformed capillaries were observed in the prosthetic interstices. The endothelial lining formed on the grafted prosthesis was somewhat unstable, showing areas comprised of smooth muscle cells that formed the neointima, interspersed with other zones of cell loss and white blood cell infiltration ( Fig. 3(b) and (c) ). In some specimens, the myointima persisted as an irregular flap made up of several cell strata. Electron microscopy revealed how the ePTFE maintained its normal structure 180 days after implant, with no signs of degeneration whatsoever. The ends of the recipient artery showed similar features to those corresponding to the other study groups.
Morphometry results
Morphometric measurements revealed that intimal hyperplasia was considerably reduced in the grafts subjected to cryopreservation (GII) compared to the autografts (GI). In group I, the mean thickness of the neointima was 161^4 mm (mean^SD), while this measurement was 54^2 mm for the cryoisografts; the difference between the two groups being statistically significant ðp , 0:05Þ: Intimal hyperplasia was further reduced in the ePTFE graft segments which showed a myointimal thickness of 9^3 mm such that differences between GIII and GI ðp , 0:001Þ and between GII and GIII ðp , 0:05Þ were also significant ( Table 1) .
Immunohistochemistry
Immunohistochemical analysis performed using the ED1 antibody (MCA341), specific for rat macrophages enabled us to confirm the persistence of this cell type when arterial replacement was undertaken using the prosthetic micrografts (GIII) ( Table 1 ). In this case, 13%^1 (mean^SD) of the cells were ED1-positive and could be seen to infiltrate the prosthetic interstices ( Fig. 4(a) ), the tunica adventitia ( Fig. 4(b) ) and the luminal surface. Lowest numbers were recorded for the autografts (GI), which showed a proportion of 2%^0.6 in hyperplasic areas ( Fig. 4(c) ), mainly close to the suture sites, and in the adventitia. The previously cryopreserved grafts (GII) showed values closer to those for GI (3%^0.3), with macrophages also showing a preference for areas of hyperplasia ( Fig. 4(d) ) and sites of anastomosis ( Fig. 4(e) ). These last groups (GI and II) did not vary amongst each other in terms of ED1-positive cells but both differed significantly ðp , 0:05Þ when compared to the ePTFE group. Differentiated smooth muscle cells were identified using the anti a-actin antibody. These cells comprised the tunica neointima in groups I and II ( Fig. 5(a) and (b)). In the ePTFE micrografts, a-actin-positive cells formed part of the hyperplasia in zones in which it was apparent ( Fig. 5(c) ), and were also observed within the prosthetic material ( Fig. 5(d) and (e)). Areas of angiogenesis were observed in the ePTFE interstices, in which the cells comprising the vessels in the inner prosthesis became labelled with the antibody for a-actin ( Fig. 5(d) ).
Discussion
In this experimental study, we were able to confirm the excellent patency of both the autografts and cryopreserved grafts, which was reduced in the group of ePTFE implants. Similar patency rates have been described using cryopreserved grafts, 16, 17 though those reported for ePTFE are generally lower, 18, 19 mainly due to thrombosis.
The hyperplasic response shown by the three graft models has been inconsistent. In the autografts, an almost consolidated hyperplasia can be observed three months after implant, while this response is significantly delayed in cryopreserved grafts. In similar experiments performed by Motomura et al. 20 using fresh and cryopreserved grafts, similar cell loss was observed in the medial layer but cryopreserved grafts showed the opposite outcome of a faster hyperplasic response. This difference could be attributable to the rat strain or vascular setting of the implanted grafts. Others 16 have reported good long-term results for the use of cryoisografts as conduits as well as considerable intimal hyperplasia in Fisher rats grafted in the femoral artery setting. Prosthetic ePTFE grafts also induce the delayed formation of the myointima with its greatest thickness achieved three months after implant, 21 followed by a drop in thickness.
This different development of the myointima shown in the three models could be related to cell behaviour in the medial layer. In the autografts, since this layer is complete and is only subjected to transient ischaemia during grafting, smooth muscle cell migration towards the subintimal space is promoted. In contrast, in the cryopreserved grafts, the cryopreservation process itself provokes intense and irreversible structural changes to the smooth muscle cells resulting in their death. 4 This event is confirmed by the findings of other authors, 22 who noted a significant drop in the number of cells of the medial layer following cryopreservation. This would suggest that after grafting, the already altered media of the cryograft is unable to quickly generate a neointima, explaining its delayed appearance. In this case, the neointima probably forms at the expense of the recipient artery ends. The autografts also undergo degeneration of the media, but this occurs much later than in the cryografts. 12 In a recent study, Giglia et al. 23 also observed diminished smooth muscle cell proportions in the medial layer, both in autografts and cryografts.
In the ePTFE grafts, hyperplasia commences at the ends of the recipient artery as occurs in the cryopreserved grafts. A neoadventitia is also generated outside the prosthesis such that the biomaterial becomes trapped in a pocket that takes on the role of the medial layer.
Our hypothesis on the repair process in the three models is that in the long-term, the cell-lacking medial layer in both autografts and cryografts could resemble the synthetic ePTFE prosthesis, given its role is to support the vascular wall and act as an inert conducting tube. In the autografts, the myointimal layer itself would take on the role of the medial layer. 14 In conclusion, all three vessel substitutes show good long-term tolerance when used in an arterial setting. Following long-term implant, autografts and cryoisografts show similar alterations that give rise to the complete loss of the muscle component of the tunica media along with the formation of a stable neointima. This new layer takes on the role of the tunica media.
Similar behaviour is shown when the arterial medial layer is replaced with ePTFE. After grafting an arterial substitute, the newly formed intima constitutes the repair response that restores the homeostatic continuity of the arterial graft.
